In-Depth Research On:
AVEO Pharmaceuticals, Inc. (AVEO)
Sign Up Now to Download a Free Research Report on AVEO
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? AVEO Pharmaceuticals, Inc.
AVEO Oncology is dedicated to discovering, developing and commercializing targeted therapies to impact the lives of patients living with cancer. They have built a robust pipeline of anti-cancer therapeutics through the use of our proprietary Human Response Platform. The company has submitted a New Drug Application (NDA) that is currently under review by the FDA seeking approval for tivozanib in patients with advanced renal cell carcinoma.
Going forward ... (see research report)
